Preferred Label : Pharmacogenomic Test;
NCIt definition : Any assay intended to study interindividual variations in whole-genome or candidate
gene, single-nucleotide polymorphism (SNP) maps, haplotype markers, or alterations
in gene expression or inactivation that may be correlated with pharmacological function
and therapeutic response.;
Alternative definition : FDA: An assay intended to study interindividual variations in whole-genome or candidate
gene, single-nucleotide polymorphism (SNP) maps, haplotype markers, or alterations
in gene expression or inactivation that may be correlated with pharmacological function
and therapeutic response. In some cases, the pattern or profile of change is the relevant
biomarker, rather than changes in individual markers.; CDISC-GLOSS: An assay intended to study interindividual variations in whole genome
or candidate gene maps, biomarkers, and alterations in gene expression or inactivation
that may be correlated with pharmacological function and therapeutic response. Compare
to pharmacogenetic test.;
NCI Metathesaurus CUI : CL524166;
Origin ID : C68762;
UMLS CUI : C2347501;
Automatic exact mappings (from CISMeF team)
- CISMeF manual mappings
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
